Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LUNA HIV latency reversal trial
NL-OMON50727Active, not recruiting
- Sponsor
- Erasmus MC
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of pyrimethamine and valproic acid in human immunodeficiency virus infection (HIV), sponsored by Erasmus MC. Primary endpoint: Change in HIV reservoir reactivation at week 2. Started Apr 2018; status: active, not recruiting.
02
Drugs
pyrimethaminevalproic acid
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NL-OMON50727.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON50727.